Open AccessReduced serum sRANKL and sTREM2 levels in high-grade gliomas: association with prognosis
Author(s) -
Mustafa Efendioğlu,
Elif Şanlı,
Ceren Türkoğlu,
Naci Balak
Publication year - 2020
Publication title -
nöropsikiyatri arşivi
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.417
H-Index - 14
ISSN - 1309-4866
DOI - 10.29399/npa.27536
Subject(s) - medicine , biomarker , immunohistochemistry , glioma , oncology , glioblastoma , overall survival , cancer research , biology , biochemistry
High-grade gliomas (HGG), including Glioblastoma multiforme (GBM), account for the majority of primary brain tumors. Nevertheless, prognostic and diagnostic biomarkers are quite limited for HGG. The objective of this study was to investigate the prognostic value of sRANKL and sTREM2 levels in HGG patients.